| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81270SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35288-10ug | |||
| Carrier-Free | NBP2-35288-1mg | |||
| Carrier-Free | NBP2-35288-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35220-10ug | |||
| Carrier-Free | NBP2-35220-1mg | |||
| Carrier-Free | NBP2-35220-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09020-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52715-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12077-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81051-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75193-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81098-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12004-0.025mg | |||
![Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.](http://images.novusbio.com/fullsize/CCR4-Antibody-KW-0761-Mogamulizumab-Chimeric-Western-Blot-NBP2-81270-img0001.jpg "Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.")
![SDS-Page: Rat SCF/c-kit Ligand Protein [NBP2-35288]](http://images.novusbio.com/fullsize/Rat-SCF-c-kit-Ligand-Protein-SDS-Page-NBP2-35288-img0001.jpg "SDS-Page: Rat SCF/c-kit Ligand Protein [NBP2-35288]")
![SDS-Page: Recombinant Rat IL-13 Protein [NBP2-35220]](http://images.novusbio.com/fullsize/Recombinant-Rat-IL-13-Protein-SDS-Page-NBP2-35220-img0002.jpg "SDS-Page: Recombinant Rat IL-13 Protein [NBP2-35220]")
![Flow Cytometry: TCR beta Antibody (H57-597) [Unconjugated] [NBP2-69071] - C57BL/6 mouse splenocytes were stained with Hamster Anti-Mouse TCR beta-AF700 and Rat Anti-Mouse CD19-FITC.](http://images.novusbio.com/fullsize/TCR-beta-Antibody-H57-597-Unconjugated-Flow-Cytometry-NBP2-69071-img0001.jpg "Flow Cytometry: TCR beta Antibody (H57-597) [Unconjugated] [NBP2-69071] - C57BL/6 mouse splenocytes were stained with Hamster Anti-Mouse TCR beta-AF700 and Rat Anti-Mouse CD19-FITC.")
![SDS-Page: Recombinant Human Lymphotoxin-alpha/TNF-beta Protein [NBP2-61307]](http://images.novusbio.com/fullsize/Recombinant-Human-Lymphotoxin-alpha-TNF-beta-Protein-SDS-Page-NBP2-61307-img0002.jpg "SDS-Page: Recombinant Human Lymphotoxin-alpha/TNF-beta Protein [NBP2-61307]")
![Immunocytochemistry/Immunofluorescence: CD53 Antibody (161-2 (53/2)) - Chimeric [NBP3-12077] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 161-2 (53/2) (NBP3-12077) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12077, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CD53-Antibody-161-2-53-2-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12077-img0001.jpg "Immunocytochemistry/Immunofluorescence: CD53 Antibody (161-2 (53/2)) - Chimeric [NBP3-12077] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 161-2 (53/2) (NBP3-12077) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12077, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: Integrin alpha 2b/CD41 Antibody (7E3 (Abciximab)) [NBP2-81051] - Flow-cytometry using the [NBP2-81051]. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of Abciximab (NBP2-81051, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/Integrin-alpha-2b-CD41-Antibody-7E3-Abciximab-Flow-Cytometry-NBP2-81051-img0001.jpg "Flow Cytometry: Integrin alpha 2b/CD41 Antibody (7E3 (Abciximab)) [NBP2-81051] - Flow-cytometry using the [NBP2-81051]. Human lymphocytes were stained with an isotype control (NBP2-52638, panel A) or the rabbit-chimeric version of Abciximab (NBP2-81051, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Immunofluorescence: IL6R Antibody (rhPM-1 (Tocilizumab)) - Chimeric [NBP2-75193] - Immunofluorescence staining of fixed U937 cells with anti-IL-6 receptorantibody rhPM-1 (Tocilizumab). Immunofluorescence analysis of paraformaldehyde fixed U937 cells on coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of rhPM-1 (Tocilizumab) (NBP2-75193) at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-75193, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/IL6R-Antibody-rhPM-1-Tocilizumab-Chimeric-Immunofluorescence-NBP2-75193-img0001.jpg "Immunofluorescence: IL6R Antibody (rhPM-1 (Tocilizumab)) - Chimeric [NBP2-75193] - Immunofluorescence staining of fixed U937 cells with anti-IL-6 receptorantibody rhPM-1 (Tocilizumab). Immunofluorescence analysis of paraformaldehyde fixed U937 cells on coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of rhPM-1 (Tocilizumab) (NBP2-75193) at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-75193, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")
![Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (H22) - Chimeric [NBP2-81098] - Immunofluorescence staining of fixed U937 cells with Fc gamma RI/CD64 Antibody (H22) [NBP2-81098]. Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of H22 [NBP2-81098] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81098, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/Fc-gamma-RI-CD64-Antibody-H22-Chimeric-Immunocytochemistry-Immunofluorescence-NBP2-81098-img0001.jpg "Immunocytochemistry/Immunofluorescence: Fc gamma RI/CD64 Antibody (H22) - Chimeric [NBP2-81098] - Immunofluorescence staining of fixed U937 cells with Fc gamma RI/CD64 Antibody (H22) [NBP2-81098]. Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix coverslips, permeabilized with 0.15% Triton and stained with the chimeric rabbit IgG version of H22 [NBP2-81098] at 10 ug/ml for 1h followed by Alexa Fluor 488 secondary antibody (1 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP2-81098, DAPI, merged channels and an isotype control. The isotype control was stained with an anti-Fluorescein antibody followed by Alexa Fluor 488 secondary antibody.")